Clearside Biomedical's revenue meets expectations, while profits exceed forecasts.
Daily NewsAccording to the Clearside Biomedical (NASDAQ: CLSD) report, the earnings per share for the first quarter came in at -$0.100, aligning with analysts' expectations...
Read More